Furthermore, DNA-PKcs specific inhibitor NU7026 markedly abated hypoxia-induced right ventricular systolic pressure (RVSP) and right ventricular hypertrophy index [RV/(LV + S)] (Fig. 5C, D). The gene discussed is PRKDC; the disease is Right ventricular hypertrophy.